Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:

  • Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the 33rd Annual Piper Sandler Virtual Healthcare Conference on Wednesday, December 1, 2021 at 2:30 PM (ET). The presentation will be concurrently webcast.

The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations.”

About DexCom, Inc.

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

Dexcom Inc. Stock

€74.43
2.910%
There is an upward development for Dexcom Inc. compared to yesterday, with an increase of €2.07 (2.910%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Dexcom Inc. stock is not clear.
Like: 0
Share
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Comments